Back
Theriva Biologics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
TOVX
Theriva Biologics, Inc.
Last Price:
$0.19
Seasonality Move:
0.43%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
Theriva Biologics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.21 | Sell |
| 20-day SMA: | 0.2 | Sell |
| 50-day SMA: | 0.23 | Sell |
| 200-day SMA: | 0.5 | Sell |
| 8-day EMA: | 0.2 | Sell |
| 20-day EMA: | 0.18 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.04 | Buy |
Theriva Biologics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 38.87 | Sell |
| Chaikin Money Flow: | -4242221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.19 - 0.23) | Sell |
| Bollinger Bands (100): | (0.21 - 0.43) | Sell |
Theriva Biologics, Inc. Technical Analysis
| Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theriva Biologics, Inc. Stock
Is Theriva Biologics, Inc. Stock a Buy?
-
Theriva Biologics, Inc. share price is 0.18 while TOVX 8-day simple moving average is 0.21, which is a Sell signal.
-
The stock price of TOVX is 0.18 while Theriva Biologics, Inc. 20-day SMA is 0.20, which makes it a Sell.
-
Theriva Biologics, Inc. 50-day simple moving average is 0.23 while TOVX share price is 0.18, making it a Sell technically.
-
TOVX stock price is 0.18 and Theriva Biologics, Inc. 200-day simple moving average is 0.50, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
14
Theriva Biologics, Inc. (TOVX)
is a Sell
Is Theriva Biologics, Inc. a Buy or a Sell?
-
Theriva Biologics, Inc. stock is rated a SellThe current Theriva Biologics, Inc. [TOVX] share price is $0.18. The Score for TOVX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics, Inc. Stock Info
Market Cap:
6.1M
Price in USD:
0.18
Share Volume:
4.7M
Theriva Biologics, Inc. 52-Week Range
52-Week High:
1.75
52-Week Low:
0.17
Sell
14
Theriva Biologics, Inc. (TOVX)
is a Sell
Theriva Biologics, Inc. Share Price Forecast
-
What is the Theriva Biologics, Inc. stock price today?The Theriva Biologics, Inc. stock price is 0.18 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics, Inc. is overvalued.
Is Theriva Biologics, Inc. Stock a Buy?
-
Theriva Biologics, Inc. share price is 0.18 while TOVX 8-day exponential moving average is 0.20, which is a Sell signal.
-
The stock price of TOVX is 0.18 while Theriva Biologics, Inc. 20-day EMA is 0.18, which makes it a Buy.
-
Theriva Biologics, Inc. 50-day exponential moving average is 0.11 while TOVX share price is 0.18, making it a Buy technically.
-
TOVX stock price is 0.18 and Theriva Biologics, Inc. 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of Theriva Biologics, Inc.
Is Theriva Biologics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Theriva Biologics, Inc.
Should I short Theriva Biologics, Inc. stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Theriva Biologics, Inc. is a Buy
-
Theriva Biologics, Inc. Relative Strength Index (RSI) is 38.87, which suggest Theriva Biologics, Inc. is oversold
-
The Bollinger Bands (25) for Theriva Biologics, Inc. is (0.19 - 0.23), which suggest Theriva Biologics, Inc. is a Sell
-
The Bollinger Bands (100) for Theriva Biologics, Inc. is (0.21 - 0.43), which suggest Theriva Biologics, Inc. is a Sell
* Theriva Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.